Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia - The case in favour

Paediatric Respiratory Reviews

Volumn 15, Issue 1, 2014, Pages 49-52

  Thomas, Wolfgang ^a   Speer, Christian P ^b  

^a Klinik Mutterhaus der Borromaeerinnen   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Chronic lung disease of infancy; Fetal inflammatory response syndrome; Prematurity

Indexed keywords

BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; FEMALE; HEALTH; HUMAN; INCIDENCE; INFANT, PREMATURE, DISEASES; NEWBORN; PATHOLOGY; PLACENTA; PREGNANCY; PREMATURITY; PRENATAL DIAGNOSIS; RISK FACTOR;

BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; FEMALE; GLOBAL HEALTH; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PLACENTA; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 84893965027     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2013.09.004     Document Type: Review

References (43)

1. Thomas W., Speer C.P. Chorioamnionitis: Important risk factor or innocent bystander for neonatal outcome?. Neonatology 2011, 99:177-187.
2. Andrews W.W., Goldenberg R.L., Faye-Petersen O., Cliver S., Goepfert A.R., Hauth J.C. The Alabama preterm birth study: Polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. Am J Obstet Gynecol 2006, 195:803-808.
3. Leviton A., Allred E.N., Kuban K.C., Hecht J.L., Onderdonk A.B., O'Shea T.M., Paneth N. Microbiologic and histological characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. The ELGAN study. Pediatr Res 2010, 67:95-101.
4. Yoon B.H., Romero R., Kim C.J., Jun J.K., Gomez R., Choi J.H., Syn H.C. Amniotic fluid interleukin-6: A sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995, 172:960-970.
5. Gotsch F., Romero R., Kusanovic J.P., Mazaki-Tovi S., Pineles B.L., Erez O., Espinoza J., Hassan S.S. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007, 50:652-683.
6. McElrath T.F., Hecht J.L., Dammann O., Boggess K., Onderdonk A., Markenson G., Harper M., Delpapa E., Allred E.N., Leviton A. Pregnancy disorders that lead to delivery before the 28th week of gestation: An epidemiologic approach to classification. Am J Epidemiol 2008, 168:980-989.
7. Onderdonk A.B., Delaney M.L., DuBois A.M., Allred E.N., Leviton A. Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol 2008, 198. 110 e111-e117.
8. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 2000, 342:1500-1507.
9. Muglia L.J., Katz M. The enigma of spontaneous preterm birth. N Engl J Med 2010, 362:529-535.
10. Been J.V., Zimmermann L.J. Histologicalal chorioamnionitis and respiratory outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed 2009, 94:F218-F225.
11. Jobe A.H. The new bronchopulmonary dysplasia. Curr Opin Pediatr 2011, 23:167-172.
12. Philip A.G. Bronchopulmonary dysplasia: then and now. Neonatology 2012, 102:1-8.
13. Speer C.P. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009, 95:353-361.
14. Speer C.P. Neonatal Respiratory Distress Syndrome: An Inflammatory Disease?. Neonatology 2011, 99:316-319.
15. Groneck P., Götze-Speer B., Oppermann M., Eiffert H., Speer C.P. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994, 93:712-718.
16. Kramer B.W., Kramer S., Ikegami M., Jobe A.H. Injury, inflammation and remodeling in fetal sheep lung after intra-amniotic endotoxin. Am J Physiol Lung Cell Mol Physiol 2001, 283:L452-L459.
17. Willet K.E., Jobe A.H., Ikegami M., Newnham J., Brennan S., Sly P.D. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr Res 2000, 48:782-788.
18. Husain A.N., Siddiqui N.H., Stocker J.T. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998, 29:710-717.
19. Schmidt B., Cao L., Mackensen-Haen S., Kendziorra H., Klingel K., Speer C.P. Chorioamnionitis and inflammation of the fetal lung. Am J Obstet Gynecol 2001, 184:173-177.
20. May M., Marx A., Seidenspinner S., Speer C.P. Apoptosis and proliferation in lungs of human fetuses exposed to chorioamnionitis. Histopathology 2004, 45:283-290.
21. Watterberg K.L., Demers L.M., Scott S.M., Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996, 97:210-215.
22. Been J.V., Degraeuwe P.L., Kramer B.W., Zimmermann L.J. Antenatal steroids and neonatal outcome after chorioamnionitis: A meta-analysis. BJOG 2011, 118:113-122.
23. Yost C.C., Soll R.F. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000, CD001456.
24. Dempsey E., Chen M.F., Kokottis T., Vallerand D., Usher R. Outcome of neonates less than 30 weeks gestation with histological chorioamnionitis. Am J Perinatol 2005, 22:155-159.
25. Lahra M.M., Beeby P.J., Jeffery H.E. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: A 13-year hospital cohort study. Pediatrics 2009, 123:1314-1319.
26. Lau J., Magee F., Qiu Z., Hoube J., Von Dadelszen P., Lee S.K. Chorioamnionitis with a fetal inflammatory response is associated with higher neonatal mortality, morbidity, and resource use than chorioamnionitis displaying a maternal inflammatory response only. Am J Obstet Gynecol 2005, 193:708-713.
27. Ogunyemi D., Murillo M., Jackson U., Hunter N., Alperson B. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med 2003, 13:102-109.
28. Dessardo N.S., Mustac E., Dessardo S., Banac S., Peter B., Finderle A., Maric M., Haller H. Chorioamnionitis and chronic lung disease of prematurity: a path analysis of causality. Am J Perinatol 2012, 29:133-140.
29. Been J.V., Rours I.G., Kornelisse R.F., Jonkers F., de Krijger R.R., Zimmermann L.J. Chorioamnionitis alters the response to surfactant in preterm infants. J Pediatr 2010, 156:10-15.
30. Ghezzi F., Gomez R., Romero R., Yoon B.H., Edwin S.S., David C., Janisse J., Mazor M. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol 1998, 78:5-10.
31. Yoon B.H., Romero R., Jun J.K., Park K.H., Park J.D., Ghezzi F., Kim B.I. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997, 177:825-830.
32. Lee J., Oh K.J., Yang H.J., Park J.S., Romero R., Yoon B.H. The importance of intra-amniotic inflammation in the subsequent development of atypical chronic lung disease. J Matern Fetal Neonatal Med 2009, 22:917-923.
33. Yoon B.H., Romero R., Kim K.S., Park J.S., Ki S.H., Kim B.I., Jun J.K. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999, 181:773-779.
34. Groneck P., Götze-Speer B., Speer C.P. Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth. Arch Dis Child Fetal Neonatal Ed 1996, 74:F51-F55.
35. Schelonka R.L., Katz B., Waites K.B., Benjamin D.K. Critical appraisal of the role of ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J 2005, 24:1033-1039.
36. Goldenberg R.L., Andrews W.W., Goepfert A.R., Faye-Petersen O., Cliver S.P., Carlo W.A., Hauth J.C. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol 2008, 198. 43.e1-5.
37. Romero R., Garite T.J. Twenty percent of very preterm neonates (23-32 weeks of gestation) are born with bacteremia caused by genital mycoplasmas. Am J Obstet Gynecol 2008, 198:1-3.
38. Hartling L., Liang Y., Lacaze-Masmonteil T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: A systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2012, 97:F8-F17.
39. Bland R. Neonatal chronic lung disease in the post-surfactant era. Biol Neonate 2005, 88:181-191.
40. Van Marter L.J., Dammann O., Allred E.N., Leviton A., Pagano M., Moore M., Martin C. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002, 140:171-176.
41. Klinger G., Levy I., Sirota L., Boyko V., Lerner-Geva L., Reichman B. Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics 2010, 125:e736-e740. in collaboration with the Israel Neonatal Network.
42. Alexander J.M., Gilstrap L.C., Cox S.M., McIntire D.M., Leveno K.J. Clinical chorioamnionitis and the prognosis for very low birth weight infants. Obstet Gynecol 1998, 91:725-729.
43. Strunk T., Doherty D., Jacques A., Simmer K., Richmond P., Kohan R., Charles A., Burgner D. Histologic chorioamnionitis is associated with reduced risk of late-onset sepsis in preterm infants. Pediatrics 2012, 129:e134-e141.